← Mechanisms of action
MAGEA3
SINGLE PROTEINHomo sapiens
Preferred name: Melanoma-associated antigen 3 ChEMBL ↗
Linked proteins
Drugs acting on this target (23)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| ima401 | Binding agent | experimental | mAb | MAGEA3 binding agent |
| adma3 | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| Biropepimut | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| chadox1-magea3-nyeso | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| d1/3-mage-3-his fusion protein | Immunity, active | experimental | Biological | immunity, active - mage3 |
| gsk1572932a | Immunity, active | experimental | Biological | MAGEA3 immunity, active |
| hla-a1-binding mage-1/mage-3 multipeptide-pulsed autologous dendritic cell vaccine | Immunity, active | experimental | Cell therapy | immunity, active - mage3 |
| mage-10.a2 | Immunity, active | experimental | Biological | MAGEA3 immunity, active |
| mage-3 | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| mage-3.1 antigen | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| mage-3.a1 | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| mage-3.a1 peptide | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| mage-a3 and ny-eso-1 | Immunity, active | experimental | Biological | MAGEA3 immunity, active |
| mage-a3 asci | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| mage-a3 peptide | Immunity, active | experimental | Biological | MAGEA3 immunity, active |
| mva-magea3 | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| recmage-a3 | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| Zastumotide | Immunity, active | experimental | Vaccine | MAGEA3 immunity, active |
| Afamitresgene autoleucel | Immunity, passive | approved | Cell therapy | MAGEA3 immunity, passive |
| anti-mage-a3 hlaa* 01-restricted tcr | Immunity, passive | experimental | Cell therapy | MAGEA3 immunity, passive |
| anti-mage-a3-dp4 tcr | Immunity, passive | experimental | Cell therapy | MAGEA3 immunity, passive |
| kite-718 | Immunity, passive | experimental | Cell therapy | MAGEA3 immunity, passive |
| pg13-mage-a3 tcr9w11 transduced autologous peripheral blood lymphocytes | Immunity, passive | experimental | Cell therapy | MAGEA3 immunity, passive |